Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma ...Middle East

LUND, Sweden, March 3, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (NASDAQ Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Matthew Shaulis will join the company effective 16 March as Chief Commercial Officer and President of the U....

Read More Details
Finally We wish PressBee provided you with enough information of ( Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma )

Also on site :

• 'General Hospital' Fans Brace for 'Slap in the Face' amid Star's Return
• Scott Miller Passes Away
• Israel-Iran conflict: List of key events, June 21, 2025